Mode
Text Size
Log in / Sign up
Phase 3 Completed N=201 Randomized Single-blind Treatment

Comparison of Psychotherapy Programs to Treat Panic Disorder

Source: ClinicalTrials.gov NCT00353470 ↗
Enrolled (actual)
201
Serious AEs
1.0%
Results posted
Dec 2022
Primary outcomePrimary: Panic Disorder Severity Scale — 6.72; 5.78; 7 score on a scale — p=>0.16
◆ Published Evidence
Established
82citations · ~8 / year
Psychotherapies for Panic Disorder: A Tale of Two Sites.
The Journal of clinical psychiatry · 2016 · High-confidence link

Summary

This study will determine the relative effectiveness of three psychotherapies in treating people with a panic disorder.

Linked Publications (5)

  • Psychotherapies for Panic Disorder: A Tale of Two Sites.
    The Journal of clinical psychiatry · 2016 · 82 citations · High-confidence link
  • Processes of therapeutic change: Results from the Cornell-Penn Study of Psychotherapies for Panic Disorder.
    Journal of counseling psychology · 2020 · 25 citations · Open access · Likely link
  • Predictors and moderators of treatment dropout in cognitive-behavioral and psychodynamic therapies for panic disorder.
    Psychotherapy research : journal of the Society for Psychotherapy Research · 2021 · 23 citations · Likely link
  • In-session emotional expression predicts symptomatic and panic-specific reflective functioning improvements in panic-focused psychodynamic psychotherapy.
    Psychotherapy (Chicago, Ill.) · 2019 · 22 citations · Open access · Likely link
  • Differential effects of alliance and techniques on Panic-Specific Reflective Function and misinterpretation of bodily sensations in two treatments for panic.
    Psychotherapy research : journal of the Society for Psychotherapy Research · 2020 · 14 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Panic Disorder Severity Scale
6.72; 5.78; 7 >0.16
SECONDARY
Sheehan Disability Scale
6.4; 6.28; 6.9
SECONDARY
Clinical Global Impressions Scale
2.17; 2.16; 2.38
SECONDARY
Hamilton Depression Rating Scale
11.37; 10.18; 11.55
SECONDARY
Hamilton Anxiety Rating Scale
7.97; 7.87; 6.30
SECONDARY
Anxiety Disorder Sensitivity Index
27.07; 17.71; 19.09
SECONDARY
Brief Body Sensitivity Interpretation Questionnaire (BBSIQ)
1.80; 1.62; 1.70
SECONDARY
Panic-Specific Reflective Function
4.67; 3.67; 3.20

Eligibility Criteria

Inclusion Criteria

  • Meets DSM-IV diagnosis criteria for primary PD with or without agoraphobia
  • History of at least one spontaneous panic attack per week within the month prior to study entry

Exclusion Criteria

  • Active substance dependence within 6 months prior to study entry
  • Lifetime history of any psychotic disorder, including bipolar disorder
  • Acutely suicidal
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00353470) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search